Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

RELEASE DATE
16-Aug-2016
REGION
North America
Research Code: P8D4-01-00-00-00
SKU: HC02670-NA-MR_18913
$7,000.00
In stock
SKU
HC02670-NA-MR_18913
$7,000.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings—Pharmaceutical CMO Market

Scope and Geographic Segmentation

Market Segmentation

Methodology

Market Engineering Measurements

  • Market Overview
  • Competitor Overview
  • Total Addressable Market
  • Industry Advancement

Global Manufacturing Footprint—Key CMO Companies

Transformation of Industry Ecosystem

Trends for the FDF CMO Market

Trends for the API and Intermediates CMO Market

Key Technology Trends—Preference for Disposable Technologies

Key Technology Trends—Rising Demand of Lyophilization

Key Investment Trends

Game-changing Companies

Customer Segment Revenue Contribution Analysis

8 Big Market Themes for Contract Manufacturing

Total Pharmaceutical CMO Market Revenue Forecast

API and Intermediates CMO Market Overview

FDF CMO Market Overview

Role of CMOs in the Pharmaceutical Manufacturing Value Chain

API and Intermediates and FDF Industry Ecosystem

Demand and Market Acceptance of Customers’ Products

Changing Business Model—Rise in Virtual Pharma

Virtual Pharma—Change Makers in Pharma and Biotech Outsourcing Ecosystem

Key Characteristics Influencing CMO Selection

New Business Models

Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market

Global CMO Key Market Trends

Key Technology Trends—Inclination towards Continuous Manufacturing

Key Technology Trends—Prominence of Gamma Sterilization

Key Technology Trends—Rising Acceptance of Process Analytical Technologies (PAT)

Key Market Drivers

Key Market Restraints

Snapshot of Competitive Landscape

CMO Expansions in Products, Clinical Services, and Capacity Offerings

Differential Revenue Growth

Uncertainty Matrix—Mapping of Key CMO Industry Uncertainties

Possible Industry Overcapacity

10 Companies to Watch and Why

Key Mergers and Acquisitions

Notable Mergers and Acquisitions—CMO Industry on a Consolidation Spree

Key Merger, Acquisition, and Partnership Agreements

Key FDF CMO Segment Strategic Collaborations

Key API and Intermediates Segment Strategic Collaborations

Market Engineering Measurements

Total Pharmaceutical CMO Market Revenue Forecast

Total Pharmaceutical CMO Market Percent Revenue Forecast by Region

Total Pharmaceutical CMO Market Revenue Forecast by Region

Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type

Total Pharmaceutical CMO Market Revenue Forecast by Service Type

API and Intermediates CMO Market Overview

Value Chain of Pharmaceutical Manufacturing

Market Segmentation

API and Intermediates CMO Market Revenue Forecast

API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region

API CMO Market Percent Revenue Breakdown by Synthesis Route

API and Intermediates CMO Market Revenue Forecast by Synthesis Route

API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base

API and Intermediates CMO Market Revenue Breakdown by Customer Base

Market Segmentation

FDF CMO Market Percent Revenue Breakdown by Geographic Region

FDF CMO Market Percent Revenue Forecast by Dosage Form

FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status

FDF CMO Market Revenue Forecast

FDF CMO Market Percent Revenue Forecast by Dosage Form

FDF CMO Market Revenue Forecast by Dosage Form

Global FDF CMO Market Share Analysis

API and Intermediates CMO Market—Competitive Structure

Key CMO Breakdown by APIs and FDFs

Market Overview

Market Analysis

Market Engineering Measurements

US Pharmaceutical CMO Market Revenue Forecast

US Pharmaceutical CMO Market Revenue Forecast by Service Type

US API and Intermediates CMO Market Revenue Forecast

US FDF CMO Market Revenue Forecast

US Solid Dose Formulations Segment Revenue Forecast

US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

US Injectable Dose Formulations Segment Revenue Forecast

Pricing Analysis

PESTLE Analysis

Patheon

Patheon—Major Partnerships and Agreements

Catalent

Catalent—Major Partnerships and Agreements

Baxter Biopharma Solutions

Market Overview

Market Analysis

Market Engineering Measurements

Western European Pharmaceutical CMO Market Revenue Forecast

Western European Pharmaceutical CMO Market Revenue Forecast by Service Type

Western European FDF CMO Market Revenue Forecast by Dosage Form

Western Europe API and Intermediates CMO Market Revenue Forecast

Western Europe FDF CMO Market Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast

Pricing Analysis

PESTLE Analysis

Market Segmentation for Western Europe Breakdown

Germany FDF CMO Market Revenue Forecast

Germany FDF CMO Market Revenue Forecast by Dosage Form

Germany Solid Dose Formulations Segment Revenue Forecast

Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Germany Injectable Dose Formulations Segment Revenue Forecast

Aenova

Aenova—Major Partnerships and Agreements

Famar

Famar—Major Partnerships and Agreements

Fareva

Fareva—Major Partnerships and Agreements

DTP Laboratories

DPT Laboratories—Major Partnerships and Agreements

Vetter Pharma

Vetter Pharma—Major Partnerships and Agreements

Consort Medical (Aesica/Bespak)

Consort Medical—Major Partnerships and Agreements

Recipharm

Recipharm—Major Partnerships and Agreements

Market Overview

Market Engineering Measurements

APAC Pharmaceutical CMO Market Revenue Forecast

APAC Pharmaceutical CMO Market Revenue Forecast by Service Type

APAC API and Intermediates CMO Market Revenue Forecast

APAC FDF CMO Market Revenue Forecast

APAC FDF CMO Market Percent Revenue Forecast by Dosage Form

APAC FDF CMO Market Revenue Forecast by Dosage Form

Pricing Analysis

PESTLE Analysis

Market Segmentation for APAC Breakdown

Market Summary—China

China Pharmaceutical CMO Market Revenue Forecast

China Pharmaceutical CMO Market Revenue Forecast by Service Type

China API and Intermediates CMO Market Revenue Forecast

China FDF CMO Market Revenue Forecast

China FDF CMO Market Revenue Forecast by Dosage Form

China Solid Dose Formulations Segment Revenue Forecast

China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

China Injectable Dose Formulations Segment Revenue Forecast

China Segment Discussion

Huapont Pharm Co., Ltd

Huapont Pharm Co., Ltd—Major Partnerships and Agreements

Market Summary—India

India Pharmaceutical CMO Market Revenue Forecast

India Pharmaceutical CMO Market Revenue Forecast by Service Type

India API and Intermediates CMO Market Revenue Forecast

India FDF CMO Market Revenue Forecast

India FDF CMO Market Revenue Forecast by Dosage Form

India Solid Dose Formulations Segment Revenue Forecast

India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

India Injectable Dose Formulations Segment Revenue Forecast

Dr. Reddy’s Laboratories—Custom Pharma Services

Dr. Reddy’s Laboratories Custom Pharma Services—Major Partnerships and Agreements

Market Summary—Japan

Japan Pharmaceutical CMO Market Revenue Forecast

Japan Pharmaceutical CMO Market Revenue Forecast by Service Type

Japan API and Intermediates CMO Market Revenue Forecast

Japan FDF CMO Market Revenue Forecast

Japan FDF CMO Market Revenue Forecast by Dosage Form

Japan Solid Dose Formulations Segment Revenue Forecast

Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Japan Injectable Dose Formulations Segment Revenue Forecast

Nipro Pharma Corporation

Nipro Pharma Corporation—Custom Pharma Services

Nipro Pharma Corporation—Major Partnerships and Agreements

Major Growth Opportunities

Global API Outsourcing Scenario

Growth Opportunities in API Contract Manufacturing

Emerging CMO Business Model

Risk Sharing Model—Achievable by Sharing the Following Resources

Various Differentiation Strategies to Drive Long-term Profitability of CMOs

Global Pharmaceutical CMO Market—Final Word

Legal Disclaimer

Market Engineering Methodology

List of Other Key Companies Included in This Research Service

List of Figures
  • 1. Total Pharmaceutical CMO Market: Global Manufacturing Footprint, Global, 2015
  • 2. Total Pharmaceutical CMO Market: Key Investment Trends, Global, 2012–2015
  • 3. Total Pharmaceutical CMO Market: Game-changing Companies, Global, 2015
  • 4. Total Pharmaceutical CMO Market: Comparative Capability Analysis of Key Participants, Global, 2015
  • 5. Total Pharmaceutical CMO Market: Key Market Drivers, Global, 2016–2020
  • 6. Total Pharmaceutical CMO Market: Key Market Restraints, Global, 2016–2020
  • 7. Total Pharmaceutical CMO Market: Roles of CMOs in the Drug Development Process, Global, 2015
  • 8. Total Pharmaceutical CMO Market: CMO Expansions, Global, 2011–2016
  • 9. FDF CMO Market: Industry Capacity Analysis by Product Segment, Global, 2015
  • 10. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, 2012–2016
  • 11. Total Pharmaceutical CMO Market: Key Merger, Acquisition, and Partnership Agreements, Global, 2014–2016
  • 12. Total FDF CMO Market: Key Mergers and Acquisitions, Global, 2016
  • 13. Total API and Intermediates CMO Market: Key Mergers and Acquisitions, Global, 2015
  • 14. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
  • 15. Total Pharmaceutical CMO Market: Revenue Forecast by Region, Global, 2012–2020
  • 16. Total Pharmaceutical CMO Market: Revenue Forecast by Service Type, Global, 2012–2020
  • 17. FDF CMO Market: Revenue Forecast by Dosage Form, Global, 2012–2020
  • 18. FDF CMO Market: Pricing Analysis, Global, 2015
  • 19. FDF CMO Market: Market Share Analysis, Global, 2015
  • 20. API and Intermediates CMO Market: Competitive Structure, Global, 2015
  • 21. Total Pharmaceutical CMO Market: Key CMO Breakdown by API and FDF, Global, 2015
  • 22. Pharmaceutical CMO Market: Market Engineering Measurements, US, 2015
  • 23. FDF CMO Market: Pricing Analysis, US, 2015
  • 24. Patheon—Major Partnerships and Agreements, Global, 2012–2015
  • 25. Catalent—Major Partnerships and Agreements, Global, 2015–2016
  • 26. Pharmaceutical CMO Market: Market Engineering Measurements, Western Europe, 2015
  • 27. FDF CMO Market: Pricing Analysis, Western Europe, 2015
  • 28. Aenova—Major Partnerships and Agreements, Global, 2012–2013
  • 29. Famar—Major Partnerships and Agreements, Global, 2013–2016
  • 30. Fareva—Major Partnerships and Agreements, Global, 2012 and 2015
  • 31. DPT Laboratories—Major Partnerships and Agreements, Global, 2013, 2014, and 2016
  • 32. Vetter Pharma—Major Partnerships and Agreements, Global, 2015
  • 33. Consort Medical—Major Partnerships and Agreements, Global, 2011, 2013, and 2016
  • 34. Recipharm—Major Partnerships and Agreements, Global, 2014–2016
  • 35. Pharmaceutical CMO Market: Market Engineering Measurements, APAC, 2015
  • 36. FDF CMO Market: Revenue Forecast by Dosage Form, APAC, 2012–2020
  • 37. FDF CMO Market: Pricing Analysis, APAC, 2015
  • 38. Huapont Pharm—Major Partnerships and Agreements, Global, 2007 and 2013
  • 39. Dr. Reddy’s Laboratories—Major Partnerships and Agreements, Global, 2012, 2014, and 2015
  • 40. Nipro Pharma Corporation—Major Partnerships and Agreements, Global, 2012 and 2014
  • 41. Total Pharmaceutical CMO Market: Differentiation Strategies to Improve CMO Profitability, Global, 2015
List of Charts
  • 1. Total Pharmaceutical CMO Market: Regional Market Share, Global, 2015
  • 2. Total Pharmaceutical CMO Market: Market Segmentation, Global, 2015
  • 3. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015
  • 4. Total Pharmaceutical CMO Market: FDF CMO Trends, Global 2015
  • 5. Total Pharmaceutical CMO Market: API and Intermediates CMO Trends, Global 2015
  • 6. Total Pharmaceutical CMO Market: Customer Segment Revenue Contribution to CMOs, Global, 2015
  • 7. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
  • 8. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
  • 9. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2012–2020
  • 10. FDF CMO Market: Revenue Breakdown by Geographic Region, Global, 2012–2020
  • 11. FDF CMO Market: Percentage Segment Breakdown, Global, 2015
  • 12. Pharmaceutical Manufacturing Market: Role of CMOs in Value Chain, Global, 2015
  • 13. Total Pharmaceutical CMO Market: Factors that Adversely Affect Demand for Customer Products, Global, 2015
  • 14. Total Pharmaceutical CMO Market: Virtual Outsourcing Model, 2015
  • 15. Pharmaceutical CMO Market: Key Characteristics Influencing CMO Selection, Global, 2015
  • 16. Total Pharmaceutical CMO Market: Growth Drivers and Contribution, Global, 2015
  • 17. Total Pharmaceutical CMO Market: Map of Key CMO Industry Uncertainties, Global, 2015
  • 18. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, <2001–2016
  • 19. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020
  • 20. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015
  • 21. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Region, Global, 2012–2020
  • 22. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
  • 23. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020
  • 24. API and Intermediates CMO Market: Market Segmentation, Global, 2015
  • 25. API and Intermediates CMO Market: Revenue Forecast, Global, 2012–2020
  • 26. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
  • 27. API and Intermediates CMO Market: Percent Revenue Breakdown by Synthesis Route, Global, 2015–2020
  • 28. API and Intermediates CMO Market: Revenue Forecast by Synthesis Route, Global, 2012–2020
  • 29. API and Intermediates CMO Market: Percent Revenue Breakdown by Customer Base, Global, 2015–2020
  • 30. API and Intermediates CMO Market: Revenue Forecast by Customer Base, Global, 2012–2020
  • 31. FDF CMO Market: Market Segmentation, Global, 2015
  • 32. FDF CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020
  • 33. FDF CMO Market: Percent Revenue Breakdown by Segments, Global, 2015
  • 34. FDF CMO Market: Percent Revenue Forecast Breakdown by Segments, Global, 2020
  • 35. FDF CMO Market: Percent Revenue Breakdown by Patent Exclusivity Status, Global, 2015
  • 36. FDF CMO Market: Revenue Forecast, Global, 2012–2020
  • 37. FDF CMO Market: Percent Revenue Forecast by Dosage Form, Global, 2012–2020
  • 38. FDF CMO Market: Market Share by Company, Global, 2015
  • 39. Pharmaceutical CMO Market: Revenue Forecast, US, 2012–2020
  • 40. Pharmaceutical CMO Market: Revenue Forecast by Service Type, US, 2012–2020
  • 41. API and Intermediates CMO Market: Revenue Forecast, US, 2012–2020
  • 42. FDF CMO Market: Revenue Forecast, US, 2012–2020
  • 43. Solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
  • 44. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020
  • 45. Injectable Dose Formulations Segment: Revenue Forecast, US, 2012–2020
  • 46. Pharmaceutical CMO Market: Revenue Forecast, Western Europe, 2012–2020
  • 47. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Western Europe, 2012–2020
  • 48. FDF CMO Market: Revenue Forecast Finished Dosage Form, Western Europe, 2012–2020
  • 49. API and Intermediates CMO Market: Revenue Forecast, Western Europe, 2012–2020
  • 50. FDF CMO Market: Revenue Forecast, Western Europe, 2012–2020
  • 51. Solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
  • 52. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
  • 53. Injectable Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020
  • 54. FDF CMO Market: Revenue Forecast, Germany, 2012–2020
  • 55. FDF CMO Market: Revenue Forecast by Dosage Form, Germany, 2012–2020
  • 56. Solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
  • 57. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
  • 58. Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020
  • 59. FDF CMO Market: Revenue Forecast, UK, 2012–2020
  • 60. FDF CMO Market: Revenue Forecast by Dosage Form, UK, 2012–2020
  • 61. Solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
  • 62. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
  • 63. Injectable Dose Formulations Segment: Revenue Forecast, UK, 2012–2020
  • 64. FDF CMO Market: Revenue Forecast, France, 2012–2020
  • 65. FDF CMO Market: Revenue Forecast by Dosage Form, France, 2012–2020
  • 66. Solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
  • 67. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020
  • 68. Injectable Dose Formulations Segment: Revenue Forecast, France, 2012–2020
  • 69. FDF CMO Market: Revenue Forecast, Italy, 2012–2020
  • 70. FDF CMO Market: Revenue Forecast by Dosage Form, Italy, 2012–2020
  • 71. Solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
  • 72. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
  • 73. Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020
  • 74. FDF CMO Market: Revenue Forecast, Spain, 2012–2020
  • 75. FDF CMO Market: Revenue Forecast by Dosage Form, Spain, 2012–2020
  • 76. Solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
  • 77. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
  • 78. Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020
  • 79. FDF CMO Market: Revenue Forecast, Scandinavia, 2012–2020
  • 80. FDF CMO Market: Revenue Forecast by Dosage Form, Scandinavia, 2012–2020
  • 81. Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
  • 82. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
  • 83. Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020
  • 84. FDF CMO Market: Revenue Forecast, Benelux, 2012–2020
  • 85. FDF CMO Market: Revenue Forecast by Dosage Form, Benelux, 2012–2020
  • 86. Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
  • 87. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
  • 88. Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020
  • 89. Pharmaceutical CMO Market: Revenue Forecast, APAC, 2012–2020
  • 90. Pharmaceutical CMO Market: Revenue Forecast by Service Type, APAC, 2012–2020
  • 91. API and Intermediates CMO Market: Revenue Forecast, APAC, 2012–2020
  • 92. FDF CMO Market: Revenue Forecast, APAC, 2012–2020
  • 93. FDF CMO Market: Percent Revenue Forecast by Dosage Form, APAC, 2012–2020
  • 94. Pharmaceutical CMO Market: PESTLE Analysis, APAC, 2015
  • 95. Pharmaceutical CMO Market: Revenue Forecast, China, 2012–2020
  • 96. Pharmaceutical CMO Market: Revenue Forecast by Service Type, China, 2012–2020
  • 97. API and Intermediates CMO Market: Revenue Forecast, China, 2012–2020
  • 98. FDF CMO Market: Revenue Forecast, China, 2012–2020
  • 99. FDF CMO Market: Revenue Forecast by Dosage Form, China, 2012–2020
  • 100. Solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
  • 101. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020
  • 102. Injectable Dose Formulations Segment: Revenue Forecast, China, 2012–2020
  • 103. Pharmaceutical CMO Market: Revenue Forecast, India, 2012–2020
  • 104. Pharmaceutical CMO Market: Revenue Forecast by Service Type, India, 2012–2020
  • 105. API and Intermediates CMO Market: Revenue Forecast, India, 2012–2020
  • 106. FDF CMO Market: Revenue Forecast, India, 2012–2020
  • 107. FDF CMO Market: Revenue Forecast by Dosage Form, India, 2012–2020
  • 108. Solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
  • 109. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020
  • 110. Injectable Dose Formulations Segment: Revenue Forecast, India, 2012–2020
  • 111. Pharmaceutical CMO Market: Revenue Forecast, Japan, 2012–2020
  • 112. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Japan, 2012–2020
  • 113. API and Intermediates CMO Market: Revenue Forecast, Japan, 2012–2020
  • 114. FDF CMO Market: Revenue Forecast, Japan, 2012–2020
  • 115. FDF CMO Market: Revenue Forecast by Dosage Form, Japan, 2012–2020
  • 116. Solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
  • 117. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
  • 118. Injectable Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020
  • 119. API Contract Manufacturing Market: Revenue by Region, 2012–2016
  • 120. Pharmaceutical CMO Market: Emerging Business Models, 2016
Related Research
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to commercial, and drug substrate to final drug product of the CMOs, biotech, and pharma companies. Additional goals are to analyze the dynamics catalyzing growth, profile organizations presenting significant opportunities, and outline industry consolidation trends that will continue shaping the market. The base year of analysis is 2015 and forecasts run from 2016 to 2020.
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings—Pharmaceutical CMO Market~ || Scope and Geographic Segmentation~ || Market Segmentation~ || Methodology~ || Market Engineering Measurements~ ||| Market Overview~ ||| Competitor Overview~ ||| Total Addressable Market~ ||| Industry Advancement~ || Global Manufacturing Footprint—Key CMO Companies~ || Transformation of Industry Ecosystem~ || Trends for the FDF CMO Market~ || Trends for the API and Intermediates CMO Market~ || Key Technology Trends—Preference for Disposable Technologies~ || Key Technology Trends—Rising Demand of Lyophilization~ || Key Investment Trends~ || Game-changing Companies~ || Customer Segment Revenue Contribution Analysis~ || 8 Big Market Themes for Contract Manufacturing~ | Global CMO Market Landscape~ || Total Pharmaceutical CMO Market Revenue Forecast~ || API and Intermediates CMO Market Overview~ || FDF CMO Market Overview~ || Role of CMOs in the Pharmaceutical Manufacturing Value Chain~ || API and Intermediates and FDF Industry Ecosystem~ || Demand and Market Acceptance of Customers’ Products~ || Changing Business Model—Rise in Virtual Pharma~ || Virtual Pharma—Change Makers in Pharma and Biotech Outsourcing Ecosystem~ || Key Characteristics Influencing CMO Selection~ || New Business Models~ || Comparative Capability Analysis of Key Participants in the Pharma/ Biotech Contract Outsourcing Market~ || Global CMO Key Market Trends~ || Key Technology Trends—Inclination towards Continuous Manufacturing~ || Key Technology Trends—Prominence of Gamma Sterilization~ || Key Technology Trends—Rising Acceptance of Process Analytical Technologies (PAT)~ || Key Market Drivers~ ||| Core competencies~ ||| Consolidation/ acquisitions~ ||| Increasing outsourcing volume by big pharma~ ||| Blockbuster drugs coming out of patent~ ||| Expanding services of CMOs~ ||| Increased adherence to a risk-sharing model will support virtual pharmaceutical~ ||| CDMO model~ || Key Market Restraints~ ||| Stringent regulatory requirements~ ||| Cost Pressure on pharma companies~ ||| Lack of venture capital (VC) funding for early-stage companies~ ||| Dependence on key starting materials and lack of substitutes~ ||| Lower unit volumes and new technologies~ | Competitive Playbook~ || Snapshot of Competitive Landscape~ || CMO Expansions in Products, Clinical Services, and Capacity Offerings~ || Differential Revenue Growth~ || Uncertainty Matrix—Mapping of Key CMO Industry Uncertainties~ || Possible Industry Overcapacity~ || 10 Companies to Watch and Why~ | Key Merger, Acquisition, and Partnership Agreements of the Contract Manufacturing Markets~ || Key Mergers and Acquisitions~ || Notable Mergers and Acquisitions—CMO Industry on a Consolidation Spree~ || Key Merger, Acquisition, and Partnership Agreements~ || Key FDF CMO Segment Strategic Collaborations~ || Key API and Intermediates Segment Strategic Collaborations~ | Forecast and Trends~ || Market Engineering Measurements~ || Total Pharmaceutical CMO Market Revenue Forecast~ || Total Pharmaceutical CMO Market Percent Revenue Forecast by Region~ || Total Pharmaceutical CMO Market Revenue Forecast by Region~ | Total Pharmaceutical CMO Market Forecast by Service Type~ || Total Pharmaceutical CMO Market Percent Revenue Forecast by Service Type~ || Total Pharmaceutical CMO Market Revenue Forecast by Service Type~ | Global API and Intermediates CMO Market Breakdown~ || API and Intermediates CMO Market Overview~ || Value Chain of Pharmaceutical Manufacturing~ || Market Segmentation~ || API and Intermediates CMO Market Revenue Forecast~ || API and Intermediates CMO Market Percent Revenue Breakdown by Geographic Region~ || API CMO Market Percent Revenue Breakdown by Synthesis Route~ || API and Intermediates CMO Market Revenue Forecast by Synthesis Route~ || API and Intermediates CMO Market Percent Revenue Breakdown by Customer Base~ || API and Intermediates CMO Market Revenue Breakdown by Customer Base~ | Global FDF CMO Market Breakdown~ || Market Segmentation~ || FDF CMO Market Percent Revenue Breakdown by Geographic Region~ || FDF CMO Market Percent Revenue Forecast by Dosage Form~ || FDF CMO Market Percent Revenue Breakdown by Patent Exclusivity Status~ || FDF CMO Market Revenue Forecast~ || FDF CMO Market Percent Revenue Forecast by Dosage Form~ || FDF CMO Market Revenue Forecast by Dosage Form~ | Market Share and Competitive Analysis~ || Global FDF CMO Market Share Analysis~ || API and Intermediates CMO Market—Competitive Structure~ || Key CMO Breakdown by APIs and FDFs~ | United States Breakdown~ || Market Overview~ || Market Analysis~ || Market Engineering Measurements~ || US Pharmaceutical CMO Market Revenue Forecast~ || US Pharmaceutical CMO Market Revenue Forecast by Service Type~ | US API and Intermediates CMO Market~ || US API and Intermediates CMO Market Revenue Forecast~ | US FDF CMO Market Breakdown~ || US FDF CMO Market Revenue Forecast~ || US Solid Dose Formulations Segment Revenue Forecast~ || US Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || US Injectable Dose Formulations Segment Revenue Forecast~ || Pricing Analysis~ || PESTLE Analysis~ | US—Key Companies to Watch~ || Patheon~ || Patheon—Major Partnerships and Agreements~ || Catalent~ || Catalent—Major Partnerships and Agreements~ || Baxter Biopharma Solutions~ | Western Europe Breakdown~ || Market Overview~ || Market Analysis~ || Market Engineering Measurements~ || Western European Pharmaceutical CMO Market Revenue Forecast~ || Western European Pharmaceutical CMO Market Revenue Forecast by Service Type~ || Western European FDF CMO Market Revenue Forecast by Dosage Form~ | Western Europe API and Intermediates CMO Market Breakdown~ || Western Europe API and Intermediates CMO Market Revenue Forecast~ | Western Europe FDF CMO Market Breakdown~ || Western Europe FDF CMO Market Revenue Forecast~ || Solid Dose Formulations Segment Revenue Forecast~ || Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Injectable Dose Formulations Segment Revenue Forecast~ || Pricing Analysis~ || PESTLE Analysis~ | Breakdown by Key Western Europe Countries~ || Market Segmentation for Western Europe Breakdown~ | Germany Breakdown~ || Germany FDF CMO Market Revenue Forecast~ || Germany FDF CMO Market Revenue Forecast by Dosage Form~ || Germany Solid Dose Formulations Segment Revenue Forecast~ || Germany Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Germany Injectable Dose Formulations Segment Revenue Forecast~ | UK Breakdown~ | France Breakdown~ | Italy Breakdown~ | Spain Breakdown~ | Scandinavia Breakdown~ | Benelux Breakdown~ | Western Europe—Key Companies to Watch~ || Aenova~ || Aenova—Major Partnerships and Agreements~ || Famar~ || Famar—Major Partnerships and Agreements~ || Fareva~ || Fareva—Major Partnerships and Agreements~ || DTP Laboratories~ || DPT Laboratories—Major Partnerships and Agreements~ || Vetter Pharma~ || Vetter Pharma—Major Partnerships and Agreements~ || Consort Medical (Aesica/Bespak)~ || Consort Medical—Major Partnerships and Agreements~ || Recipharm~ || Recipharm—Major Partnerships and Agreements~ | APAC Breakdown~ || Market Overview~ || Market Engineering Measurements~ || APAC Pharmaceutical CMO Market Revenue Forecast~ || APAC Pharmaceutical CMO Market Revenue Forecast by Service Type~ | APAC API and Intermediates CMO Market Breakdown~ || APAC API and Intermediates CMO Market Revenue Forecast~ | APAC FDF CMO Market Breakdown~ || APAC FDF CMO Market Revenue Forecast~ || APAC FDF CMO Market Percent Revenue Forecast by Dosage Form~ || APAC FDF CMO Market Revenue Forecast by Dosage Form~ || Pricing Analysis~ || PESTLE Analysis~ | Breakdown by Key APAC Countries~ || Market Segmentation for APAC Breakdown~ | China Breakdown~ || Market Summary—China~ || China Pharmaceutical CMO Market Revenue Forecast~ || China Pharmaceutical CMO Market Revenue Forecast by Service Type~ || China API and Intermediates CMO Market Revenue Forecast~ || China FDF CMO Market Revenue Forecast~ || China FDF CMO Market Revenue Forecast by Dosage Form~ || China Solid Dose Formulations Segment Revenue Forecast~ || China Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || China Injectable Dose Formulations Segment Revenue Forecast~ || China Segment Discussion~ || Huapont Pharm Co., Ltd~ || Huapont Pharm Co., Ltd—Major Partnerships and Agreements~ | India Breakdown~ || Market Summary—India~ || India Pharmaceutical CMO Market Revenue Forecast~ || India Pharmaceutical CMO Market Revenue Forecast by Service Type~ || India API and Intermediates CMO Market Revenue Forecast~ || India FDF CMO Market Revenue Forecast~ || India FDF CMO Market Revenue Forecast by Dosage Form~ || India Solid Dose Formulations Segment Revenue Forecast~ || India Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || India Injectable Dose Formulations Segment Revenue Forecast~ || Dr. Reddy’s Laboratories—Custom Pharma Services~ || Dr. Reddy’s Laboratories Custom Pharma Services—Major Partnerships and Agreements~ | Japan Breakdown~ || Market Summary—Japan~ || Japan Pharmaceutical CMO Market Revenue Forecast~ || Japan Pharmaceutical CMO Market Revenue Forecast by Service Type~ || Japan API and Intermediates CMO Market Revenue Forecast~ || Japan FDF CMO Market Revenue Forecast~ || Japan FDF CMO Market Revenue Forecast by Dosage Form~ || Japan Solid Dose Formulations Segment Revenue Forecast~ || Japan Liquid and Semi-solid Dose Formulations Segment Revenue Forecast~ || Japan Injectable Dose Formulations Segment Revenue Forecast~ || Nipro Pharma Corporation~ || Nipro Pharma Corporation—Custom Pharma Services~ || Nipro Pharma Corporation—Major Partnerships and Agreements~ | The Last Word—Strategic Considerations for Staying on Growth Trajectory~ || Major Growth Opportunities~ || Global API Outsourcing Scenario~ || Growth Opportunities in API Contract Manufacturing~ || Emerging CMO Business Model~ || Risk Sharing Model—Achievable by Sharing the Following Resources~ || Various Differentiation Strategies to Drive Long-term Profitability of CMOs~ || Global Pharmaceutical CMO Market—Final Word~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || List of Other Key Companies Included in This Research Service~
List of Charts and Figures 1. Total Pharmaceutical CMO Market: Global Manufacturing Footprint, Global, 2015~ 2. Total Pharmaceutical CMO Market: Key Investment Trends, Global, 2012–2015~ 3. Total Pharmaceutical CMO Market: Game-changing Companies, Global, 2015~ 4. Total Pharmaceutical CMO Market: Comparative Capability Analysis of Key Participants, Global, 2015~ 5. Total Pharmaceutical CMO Market: Key Market Drivers, Global, 2016–2020~ 6. Total Pharmaceutical CMO Market: Key Market Restraints, Global, 2016–2020~ 7. Total Pharmaceutical CMO Market: Roles of CMOs in the Drug Development Process, Global, 2015~ 8. Total Pharmaceutical CMO Market: CMO Expansions, Global, 2011–2016~ 9. FDF CMO Market: Industry Capacity Analysis by Product Segment, Global, 2015~ 10. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, 2012–2016~ 11. Total Pharmaceutical CMO Market: Key Merger, Acquisition, and Partnership Agreements, Global, 2014–2016~ 12. Total FDF CMO Market: Key Mergers and Acquisitions, Global, 2016~ 13. Total API and Intermediates CMO Market: Key Mergers and Acquisitions, Global, 2015~ 14. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015~ 15. Total Pharmaceutical CMO Market: Revenue Forecast by Region, Global, 2012–2020~ 16. Total Pharmaceutical CMO Market: Revenue Forecast by Service Type, Global, 2012–2020~ 17. FDF CMO Market: Revenue Forecast by Dosage Form, Global, 2012–2020~ 18. FDF CMO Market: Pricing Analysis, Global, 2015~ 19. FDF CMO Market: Market Share Analysis, Global, 2015~ 20. API and Intermediates CMO Market: Competitive Structure, Global, 2015~ 21. Total Pharmaceutical CMO Market: Key CMO Breakdown by API and FDF, Global, 2015~ 22. Pharmaceutical CMO Market: Market Engineering Measurements, US, 2015~ 23. FDF CMO Market: Pricing Analysis, US, 2015~ 24. Patheon—Major Partnerships and Agreements, Global, 2012–2015~ 25. Catalent—Major Partnerships and Agreements, Global, 2015–2016~ 26. Pharmaceutical CMO Market: Market Engineering Measurements, Western Europe, 2015~ 27. FDF CMO Market: Pricing Analysis, Western Europe, 2015~ 28. Aenova—Major Partnerships and Agreements, Global, 2012–2013~ 29. Famar—Major Partnerships and Agreements, Global, 2013–2016~ 30. Fareva—Major Partnerships and Agreements, Global, 2012 and 2015~ 31. DPT Laboratories—Major Partnerships and Agreements, Global, 2013, 2014, and 2016~ 32. Vetter Pharma—Major Partnerships and Agreements, Global, 2015~ 33. Consort Medical—Major Partnerships and Agreements, Global, 2011, 2013, and 2016~ 34. Recipharm—Major Partnerships and Agreements, Global, 2014–2016~ 35. Pharmaceutical CMO Market: Market Engineering Measurements, APAC, 2015~ 36. FDF CMO Market: Revenue Forecast by Dosage Form, APAC, 2012–2020~ 37. FDF CMO Market: Pricing Analysis, APAC, 2015~ 38. Huapont Pharm—Major Partnerships and Agreements, Global, 2007 and 2013~ 39. Dr. Reddy’s Laboratories—Major Partnerships and Agreements, Global, 2012, 2014, and 2015~ 40. Nipro Pharma Corporation—Major Partnerships and Agreements, Global, 2012 and 2014~ 41. Total Pharmaceutical CMO Market: Differentiation Strategies to Improve CMO Profitability, Global, 2015~| 1. Total Pharmaceutical CMO Market: Regional Market Share, Global, 2015~ 2. Total Pharmaceutical CMO Market: Market Segmentation, Global, 2015~ 3. Total Pharmaceutical CMO Market: Market Engineering Measurements, Global, 2015~ 4. Total Pharmaceutical CMO Market: FDF CMO Trends, Global 2015~ 5. Total Pharmaceutical CMO Market: API and Intermediates CMO Trends, Global 2015~ 6. Total Pharmaceutical CMO Market: Customer Segment Revenue Contribution to CMOs, Global, 2015~ 7. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020~ 8. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015~ 9. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2012–2020~ 10. FDF CMO Market: Revenue Breakdown by Geographic Region, Global, 2012–2020~ 11. FDF CMO Market: Percentage Segment Breakdown, Global, 2015~ 12. Pharmaceutical Manufacturing Market: Role of CMOs in Value Chain, Global, 2015~ 13. Total Pharmaceutical CMO Market: Factors that Adversely Affect Demand for Customer Products, Global, 2015~ 14. Total Pharmaceutical CMO Market: Virtual Outsourcing Model, 2015~ 15. Pharmaceutical CMO Market: Key Characteristics Influencing CMO Selection, Global, 2015~ 16. Total Pharmaceutical CMO Market: Growth Drivers and Contribution, Global, 2015~ 17. Total Pharmaceutical CMO Market: Map of Key CMO Industry Uncertainties, Global, 2015~ 18. Total Pharmaceutical CMO Market: Key Mergers and Acquisitions, Global, <2001–2016~ 19. Total Pharmaceutical CMO Market: Revenue Forecast, Global, 2012–2020~ 20. Total Pharmaceutical CMO Market: Percent Points Cost Comparison with the US, Global, 2015~ 21. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Region, Global, 2012–2020~ 22. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020~ 23. Total Pharmaceutical CMO Market: Percent Revenue Forecast by Service Type, Global, 2012–2020~ 24. API and Intermediates CMO Market: Market Segmentation, Global, 2015~ 25. API and Intermediates CMO Market: Revenue Forecast, Global, 2012–2020~ 26. API and Intermediates CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020~ 27. API and Intermediates CMO Market: Percent Revenue Breakdown by Synthesis Route, Global, 2015–2020~ 28. API and Intermediates CMO Market: Revenue Forecast by Synthesis Route, Global, 2012–2020~ 29. API and Intermediates CMO Market: Percent Revenue Breakdown by Customer Base, Global, 2015–2020~ 30. API and Intermediates CMO Market: Revenue Forecast by Customer Base, Global, 2012–2020~ 31. FDF CMO Market: Market Segmentation, Global, 2015~ 32. FDF CMO Market: Percent Revenue Breakdown by Geographic Region, Global, 2015–2020~ 33. FDF CMO Market: Percent Revenue Breakdown by Segments, Global, 2015~ 34. FDF CMO Market: Percent Revenue Forecast Breakdown by Segments, Global, 2020~ 35. FDF CMO Market: Percent Revenue Breakdown by Patent Exclusivity Status, Global, 2015~ 36. FDF CMO Market: Revenue Forecast, Global, 2012–2020~ 37. FDF CMO Market: Percent Revenue Forecast by Dosage Form, Global, 2012–2020~ 38. FDF CMO Market: Market Share by Company, Global, 2015~ 39. Pharmaceutical CMO Market: Revenue Forecast, US, 2012–2020~ 40. Pharmaceutical CMO Market: Revenue Forecast by Service Type, US, 2012–2020~ 41. API and Intermediates CMO Market: Revenue Forecast, US, 2012–2020~ 42. FDF CMO Market: Revenue Forecast, US, 2012–2020~ 43. Solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 44. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 45. Injectable Dose Formulations Segment: Revenue Forecast, US, 2012–2020~ 46. Pharmaceutical CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 47. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Western Europe, 2012–2020~ 48. FDF CMO Market: Revenue Forecast Finished Dosage Form, Western Europe, 2012–2020~ 49. API and Intermediates CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 50. FDF CMO Market: Revenue Forecast, Western Europe, 2012–2020~ 51. Solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 52. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 53. Injectable Dose Formulations Segment: Revenue Forecast, Western Europe, 2012–2020~ 54. FDF CMO Market: Revenue Forecast, Germany, 2012–2020~ 55. FDF CMO Market: Revenue Forecast by Dosage Form, Germany, 2012–2020~ 56. Solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 57. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 58. Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2012–2020~ 59. FDF CMO Market: Revenue Forecast, UK, 2012–2020~ 60. FDF CMO Market: Revenue Forecast by Dosage Form, UK, 2012–2020~ 61. Solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 62. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 63. Injectable Dose Formulations Segment: Revenue Forecast, UK, 2012–2020~ 64. FDF CMO Market: Revenue Forecast, France, 2012–2020~ 65. FDF CMO Market: Revenue Forecast by Dosage Form, France, 2012–2020~ 66. Solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 67. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 68. Injectable Dose Formulations Segment: Revenue Forecast, France, 2012–2020~ 69. FDF CMO Market: Revenue Forecast, Italy, 2012–2020~ 70. FDF CMO Market: Revenue Forecast by Dosage Form, Italy, 2012–2020~ 71. Solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 72. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 73. Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2012–2020~ 74. FDF CMO Market: Revenue Forecast, Spain, 2012–2020~ 75. FDF CMO Market: Revenue Forecast by Dosage Form, Spain, 2012–2020~ 76. Solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 77. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 78. Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2012–2020~ 79. FDF CMO Market: Revenue Forecast, Scandinavia, 2012–2020~ 80. FDF CMO Market: Revenue Forecast by Dosage Form, Scandinavia, 2012–2020~ 81. Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 82. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 83. Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2012–2020~ 84. FDF CMO Market: Revenue Forecast, Benelux, 2012–2020~ 85. FDF CMO Market: Revenue Forecast by Dosage Form, Benelux, 2012–2020~ 86. Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 87. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 88. Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2012–2020~ 89. Pharmaceutical CMO Market: Revenue Forecast, APAC, 2012–2020~ 90. Pharmaceutical CMO Market: Revenue Forecast by Service Type, APAC, 2012–2020~ 91. API and Intermediates CMO Market: Revenue Forecast, APAC, 2012–2020~ 92. FDF CMO Market: Revenue Forecast, APAC, 2012–2020~ 93. FDF CMO Market: Percent Revenue Forecast by Dosage Form, APAC, 2012–2020~ 94. Pharmaceutical CMO Market: PESTLE Analysis, APAC, 2015~ 95. Pharmaceutical CMO Market: Revenue Forecast, China, 2012–2020~ 96. Pharmaceutical CMO Market: Revenue Forecast by Service Type, China, 2012–2020~ 97. API and Intermediates CMO Market: Revenue Forecast, China, 2012–2020~ 98. FDF CMO Market: Revenue Forecast, China, 2012–2020~ 99. FDF CMO Market: Revenue Forecast by Dosage Form, China, 2012–2020~ 100. Solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 101. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 102. Injectable Dose Formulations Segment: Revenue Forecast, China, 2012–2020~ 103. Pharmaceutical CMO Market: Revenue Forecast, India, 2012–2020~ 104. Pharmaceutical CMO Market: Revenue Forecast by Service Type, India, 2012–2020~ 105. API and Intermediates CMO Market: Revenue Forecast, India, 2012–2020~ 106. FDF CMO Market: Revenue Forecast, India, 2012–2020~ 107. FDF CMO Market: Revenue Forecast by Dosage Form, India, 2012–2020~ 108. Solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 109. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 110. Injectable Dose Formulations Segment: Revenue Forecast, India, 2012–2020~ 111. Pharmaceutical CMO Market: Revenue Forecast, Japan, 2012–2020~ 112. Pharmaceutical CMO Market: Revenue Forecast by Service Type, Japan, 2012–2020~ 113. API and Intermediates CMO Market: Revenue Forecast, Japan, 2012–2020~ 114. FDF CMO Market: Revenue Forecast, Japan, 2012–2020~ 115. FDF CMO Market: Revenue Forecast by Dosage Form, Japan, 2012–2020~ 116. Solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 117. Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 118. Injectable Dose Formulations Segment: Revenue Forecast, Japan, 2012–2020~ 119. API Contract Manufacturing Market: Revenue by Region, 2012–2016~ 120. Pharmaceutical CMO Market: Emerging Business Models, 2016~
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Unmesh Lal
Industries Healthcare
WIP Number P8D4-01-00-00-00
Keyword 1 pharmaceutical contract manufacturing market
Keyword 2 contract manufacturing growth
Keyword 3 Contract Manufacturing Organization
Is Prebook No